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a r t I C l e S Activation of the immune system and leukocyte infiltration leads to tissue and organ injury in both acute conditions, such as IRI 1 , and chronic conditions, such as rheumatoid arthritis 2 . The cholinergic antiinflammatory pathway (CAP) has been defined as the efferent arm of a vagal reflex that limits the duration and intensity of the inflammatory response [2] [3] [4] [5] [6] . The CAP is elicited by electrical stimulation of the vagus nerve or by noninvasive ultrasound treatment 7 , procedures that have beneficial effects in a number of inflammatory models, including renal IRI 2, 8 . The CAP is mediated by the spleen and its noradrenergic innervation 9 . The intrasplenic pathway includes activation of β 2 adrenergic receptors expressed by choline acetyltransferase-positive (ChAT + ) splenic memory T cells (CD4 + CD44 high CD62L low ) 10, 11 , acetylcholine (ACh) release by these leukocytes and activation of α7 nicotinic receptors (α7nAChRs) on adjacent macrophages, leading to reduced production of proinflammatory cytokines 12 . A parallel sympathetic anti-inflammatory reflex, also converging on the spleen, contributes to the immunosuppressive effect of spinal injury 13 or anesthesia 14 .
Of note, stimulating the central or the distal end of a divided cervical vagus nerve provides equal protection against renal IRI in mice 8 . Moreover, the renal protection conferred by stimulating the central end of the vagus nerve persists even if the stimulus is delivered while the contralateral vagus nerve is blocked 8 . Altogether, this type of evidence suggests that anti-inflammatory reflexes are not exclusively vagovagal and that, in some cases, the neural component of the CAP may rely on a canonical sympathetic route (i.e., splenic noradrenergic neurons activated by sympathetic cholinergic preganglionic neurons residing in the spinal cord) 15 .
Inflammatory reflexes are almost certainly regulated by the CNS, because the CAP is activated by intracerebral administration of drugs 2, 16, 17 and brain death unleashes peripheral inflammation 18 . Identifying and, ultimately, stimulating the CNS pathways that control the CAP could be beneficial in the management of chronic inflammatory diseases, spinal injury and organ transplantation 2, 13, [18] [19] [20] .
The autonomic nervous system, notably its sympathetic division, is mobilized by physical and psychological stressors [21] [22] [23] . A subset of these autonomic responses (especially cardiovascular) is mediated or facilitated by C1s, a group of glutamatergic, catecholaminergic and peptidergic neurons that reside in the medullary reticular formation [21] [22] [23] . Acute stress also mobilizes the immune system, as evidenced by rapid reductions in thymus and spleen volume and increased leukocyte flux in blood 24 . Though better known for their role in controlling sympathetic efferents, C1s also innervate the dorsal motor nucleus of the vagus and the paraventricular nucleus of the hypothalamus 25, 26 . In addition, subsets of C1s are strongly activated by circulating interleukin-1 and lipopolysaccharide, as well as by footshock 21 . Therefore, we asked whether acute stress reduces tissue injury by activating the CAP, and we tested whether C1s are a critical node for central regulation of this neuroimmune anti-inflammatory reflex.
RESULTS

Restraint stress protects the kidneys from IRI
Most experiments were conducted in dopamine β-hydroxylasehemizygous Dbh Cre/0 (hereafter DBH-cre) mice. We first examined whether a brief period of restraint stress provided protection in a r t I C l e S an IRI model and whether the CAP contributed to the protective action. We chose to examine renal IRI, evoked by 26 min of ischemia (bilateral clamping of the renal arteries and veins) and followed by 24 h of tissue reperfusion, because renal damage can be precisely quantified by three complementary measures: plasma creatinine (a measure of kidney function), kidney Kim1 transcripts (also called Havcr1, a biomarker of renal proximal tubule injury) and histological examination of renal tubular necrosis 7, 8, 27 .
A 10-min period of physical restraint provided strong protection from kidney injury evoked by renal ischemia-reperfusion (IR) 24 h later (Fig. 1a) , as shown by lower plasma creatinine (0.44 ± 0.18 versus 1.38 ± 0.08 mg per dL; n = 6 mice per group; Fig. 1b) , reduced Kim1/Gapdh mRNA ratio (Fig. 1c) and lesser degree of tubular necrosis ( Fig. 1d and Supplementary Fig. 1 ) compared to unstressed mice. Of note, stress did not totally protect the mice against IRI; all three markers of injury were significantly higher in stressed mice subjected to renal IR than in DBH-cre mice subjected neither to stress nor renal IR (Fig. 1b-d) .
The CAP requires α7nAChRs that are expressed by splenic macrophages and, possibly, by the noradrenergic innervation of the spleen 2, 15, 28 . As an initial test of whether restraint stress protects against renal IRI by activating this pathway, we examined whether restraint protected the kidneys in a7nAChR −/− (α7KO) mice. Restraint stress did not ameliorate the renal IRI in these mice, but it effectively protected genetically matched controls (α7WT), as evidenced by a greatly reduced plasma creatinine level 24 h after renal IR (Fig. 1e) .
Seeking further evidence that restraint stress protects mice from kidney IRI by activating the CAP, we first examined whether splenocytes harvested from stressed C57BL/6 mice conferred protection against renal IRI to unstressed mice of the same strain (Fig. 2a) . Injection of splenocytes protected unstressed recipient mice from renal IRI in a dose-dependent fashion regardless of the donor, but protection required significantly fewer cells when the splenocytes originated from stressed mice (Fig. 2b) . Activation of splenic T-lymphocytes by noradrenaline is a critical stage of the CAP. We therefore tested whether administration of CD4 T-lymphocytes harvested from the spleen of unstressed C57B/6 mice and incubated with noradrenaline in vitro would protect unstressed mice from renal IRI (Fig. 2c) . This was indeed the case (Fig. 2d) .
In brief, a short period of physical restraint (10 min) protects the kidneys from IRI inflicted 24 h later. The same degree of protection was observed in two strains of mice (DBH-cre and α7WT). The protection conferred by stress was absent in α7KO mice; it was transferable to naive mice by injecting splenocytes harvested from stressed mice or by injecting splenic CD4 T cells harvested from naive mice and exposed to noradrenaline in vitro. These results suggest that restraint stress, like vagus nerve stimulation and noninvasive ultrasound 8, 27 , protected mice from renal IRI by activating the CAP.
Selective optogenetic stimulation of C1 neurons protects the kidneys from IRI C1s are activated by physical stresses such as hypoxia, hemorrhage, hypoglycemia and infection 23 and, as a group, C1s heavily innervate both sympathetic and vagal preganglionic neurons as well as the paraventricular nucleus of the hypothalamus 29 . If activated, each of these CNS output pathways could potentially elicit anti-inflammatory effects. Accordingly, we first asked whether selective stimulation of C1s also protects mice against renal IRI. Five to six weeks after injecting a FLEX (flip-excision) channelrhodopsin2 (ChR2)-mCherry vector (AAV2-DIO-EF1α-ChR2(H134R)-mCherry, hereafter AAV2-ChR2-mCherry) into the left rostral ventrolateral medulla oblongata (RVLM) of DBH-cre mice, Cre-mediated recombination and ChR2 expression was confined to tyrosine hydroxylase-immunoreactive (TH + ) neurons located within the ventrolateral medulla, 6.1-7.2 mm caudal to bregma ( Fig. 3b and Supplementary Fig. 2a ). In mice, most (>95%) TH + neurons located within this region of the medulla oblongata contain phenylethanolamine N-methyltransferase (PNMT) transcripts 30 ; therefore, most of the ChR2 + neurons were, by definition, C1 adrenergic cells. Five to six weeks after injection of the control vector into the left medulla oblongata (AAV2-DIO-EF1α-mCherry, hereafter DIO-mCherry), mCherry immunoreactivity was also confined to TH + neurons located in the RVLM (results not shown).
Unilateral optogenetic stimulation of C1s was performed in unanesthetized mice 24 h before renal IR ( Fig. 3a; optrode placements illustrated in Fig. 3b and Supplementary Fig. 2b) . In anesthetized mice, each light pulse evoked a single action potential in C1s 26 . The stimulation parameters (5 Hz, 10-ms pulses) were selected to produce a small submaximal respiratory stimulation ( Supplementary Fig. 2c-f and Supplementary Table 1 ). C1 stimulation was maintained for 10 min in order to match the duration of the restraint stress. C1 stimulation reduced behavioral activity and locomotion while eliciting a regular, slightly increased breathing rate (Supplementary Fig. 3 ). These effects ended upon cessation of the stimulus ( Supplementary  Fig. 3 ). Respiratory stimulation and reduced behavioral activity were caused by C1 activation and not by the light itself because they were undetectable in the six DBH-cre mice that had received injections of control vector (DIO-mCherry; results not shown).
Plasma creatinine, Kim1/Gapdh mRNA ratio and tubular necrosis were low in mice subjected to sham surgery and, as expected for renal IRI, these parameters were elevated 24 h after renal IR (Fig. 3c-e and Supplementary Fig. 4 ). C1 stimulation greatly reduced all three indices of renal pathology elicited by IR (Fig. 3c-e and Supplementary Fig. 4) . By contrast, blue laser illumination of the a r t I C l e S ventrolateral medulla of DBH-cre mice that had received the control vector AAV2-mCherry had no protective effect (Fig. 3c-e and Supplementary Fig. 4 ). In short: mild, selective, optogenetic stimulation of C1s produced behavioral quiescence, increased breathing slightly and protected against renal IRI inflicted 24 h later.
Renal IRI protection by restraint stress requires C1 neurons Next, we tested whether the beneficial effect of restraint stress would be attenuated in mice in which the C1s were inhibited during the stress period. We transduced C1s to express Gi-coupled designer receptors exclusively activated by designer drugs (DREADDs) 31 by injecting AAV2-DIO-hSyn-hm4D(Gi)-mCherry bilaterally into the RVLM of DBH-cre mice. When activated, this receptor inhibits neurons, such as C1s, that express inwardly rectifying potassium channels 32 . mCherry immunoreactivity, indicating the presence of DREADDs, was detected predominantly in catecholaminergic neurons (75.3 ± 2.2% of mCherry + neurons were also TH + ), and 43.2 ± 4.2% of C1s (RVLM TH + neurons) contained mCherry (Fig. 4a,b) . The lower selectivity of the DREADD-expressing AAV2 for catecholaminergic neurons relative to the other FLEX vectors (75% versus >95% TH + neurons) presumably resulted from a difference in promoter (synapsin versus EF1α). Administration of the DREADD agonist clozapine N-oxide (CNO) 15 min before restraint significantly reduced the protective effect of stress, unlike injection of vehicle (Fig. 4e) . We also examined whether the protective effect of restraint stress would be attenuated if C1s were selectively destroyed. To that end, we injected AAV2-DIO-taCasp3-TEVp, a FLEX caspase-expressing AAV2 vector, bilaterally into the RVLM of DBH-cre mice 33 . Within a week, this procedure eliminated most TH + neurons located within the brain region of interest (Fig. 4c,d ). All other (nor)adrenergic cell groups (dorsal vagal complex, dorsal medulla, locus coeruleus) appeared intact. Nonspecific tissue damage was not detected at the site of vector injection and the cholinergic neurons that are comingled with C1s were intact (Fig. 4c) . These lesions dramatically reduced the protective effect of restraint stress against renal IRI (Fig. 4e) . Thus, acute DREADD-mediated inhibition or caspase-mediated destruction of C1s eliminated the protective effect of restraint stress against renal IRI, implying an obligatory role for these brainstem cells in the stress-evoked anti-inflammatory reflex.
Corticosterone release does not account for the protective effect of C1 stimulation against renal IRI Stress activates corticosterone synthesis and release (for example, ref. 34) . A subset of C1s innervate the hypothalamic paraventricular nucleus and likely contribute to the activation of the corticotropin releasing factor (CRF)-adrenocorticotropic hormone (ACTH)-corticosterone cascade 35 . Corticosterone has anti-inflammatory effects that could conceivably explain the reduced renal damage 
a r t I C l e S
following restraint stress and/or C1 stimulation. Both restraint stress (10 min) and optogenetic activation of C1s (10 min at 5 Hz) increased plasma corticosterone in unanesthetized DBH-cre mice, although the hormonal rise elicited by C1 stimulation was smaller than that elicited by restraint (Fig. 5a,b) . The plasma corticosterone surge elicited by C1 stimulation was not caused by handling the animals nor by the light itself, because brainstem illumination did not change the corticosterone level in mice that had received injections of control vector AAV2-mCherry (Fig. 5b) .
In order to test whether corticosterone mediates the renal IRI protection elicited by C1 stimulation, we administered the corticosterone antagonist mifepristone to DBH-cre mice before stimulating C1s optogenetically. Mifepristone did not reduce the renal protective effect, suggesting that the beneficial effect of C1 stimulation against renal IRI is not mediated by the rise in plasma corticosterone (Fig. 5c ).
C1 neuron stimulation activates the autonomic nervous system
As shown before 26 , optogenetic stimulation of C1 in anesthetized DBHcre mice (10 ms pulses, 5-20 Hz, 10-s trains) produced a robust and sustained frequency-dependent increase in multifiber efferent vagus nerve activity on the ipsilateral side (Fig. 6a) . We add here that contralateral efferent vagus nerve activity was also increased by stimulating C1 at ≥5 Hz, albeit to a lesser degree (Fig. 6b) . These results accord with the existence of a dominantly ipsilateral monosynaptic excitatory connection between C1 and the dorsal motor nucleus of the vagus 25 . For technical reasons, sympathetic nerve activity was recorded from a renal nerve rather than a splenic nerve. Low-frequency stimulation of C1 (1 Hz) evoked a robust phasic response in the renal sympathetic nerve (onset latency: 59 ± 4.7 ms; peak latency: 102.8 ± 11.7 ms; Fig. 6d ). These observations agree with and extend prior evidence that C1s are excitatory and directly innervate both sympathetic and vagal parasympathetic preganglionic neurons 26 .
Contribution of spleen and autonomic nervous system to the protective effect of C1 stimulation against renal IRI In order to test whether C1 activation protects mice against renal IRI by activating the autonomic nervous system, we administered a ganglionic blocker, hexamethonium, 30 min before optogenetically stimulating C1 (Fig. 7a) . These experiments were performed in DBH-cre mice that had received unilateral injections of 7 0 4 VOLUME 20 | NUMBER 5 | MAY 2017 nature neurOSCIenCe a r t I C l e S AAV2-ChR2-mCherry 5 weeks prior. Hexamethonium greatly attenuated the renal protection elicited by C1 stimulation (Fig. 7a) ; thus activation of vagal and/or sympathetic efferents was required for C1 to protect against renal IRI. The spleen is a critical component of the CAP 3 , and electrical stimulation of the vagus nerve protects the kidneys from IRI only if the spleen is intact 8 . Splenectomy, performed 7 d before stimulating C1, also eliminated the protective effect of C1 stimulation against renal IRI (Fig. 7b) . This result, combined with the fact that C1 stimulation increases vagal and sympathetic efferent activity and the efficacy of hexamethonium, suggests that C1 stimulation, like restraint stress, protected the kidneys by activating the CAP 3 . The CAP requires activation of β 2 -adrenergic receptors expressed by splenic T cells 11 . Accordingly, we tested whether β 2 -adrenergic receptor blockade would prevent the protective effect of C1 stimulation against renal IRI (Fig. 7a) . Butoxamine, a β 2 -selective antagonist that blocks the CAP in mice 11 , eliminated the protective effect of C1 stimulation (Fig. 7a) . We also tested labetalol, a nonselective β 1 -, β 2 -and α 1 -adrenergic receptor blocker in humans. However, this agent was ineffective (results not shown), perhaps reflecting weak blockade of β 2 -receptors in mice or some consequence of its additional actions on β 1 -and/or α 1 -receptors in the CNS or elsewhere.
Both vagal and sympathetic preganglionic neurons appear capable of triggering the CAP 3, 14 . In order to identify which division of the autonomic nervous system mediates the renal IRI protection elicited by C1 stimulation we performed subdiaphragmatic vagal denervations (Fig. 7c) . First, we tested the efficacy of the surgical procedure by injecting the retrogradely transported dye Fluoro-Gold intraperitoneally. As expected, in sham-operated mice, the dye was abundantly present in the dorsal motor nucleus of the vagus (Supplementary Fig. 5 ). By contrast, Fluoro-Gold was absent from this nucleus in mice in which vagus nerve branches had been cut immediately below the diaphragm (n = 3 in each group; Supplementary Fig. 5 ). We then determined whether the renal protection produced by C1 stimulation was attenuated in mice with subdiaphragmatic vagal denervation; it was not (n = 6 mice per group; Fig. 7c) . Thus, the subdiaphragmatic vagus nerve was not required for C1 stimulation to activate the CAP and protect the kidneys from IRI. Since protection was greatly reduced by ganglionic blockade but unaffected by mifepristone, C1 most likely activated the CAP via a sympathetic route.
Restraint stress and C1 stimulation produce opposite effects on arterial pressure and heart rate Given that restraint stress and C1 stimulation were equally effective at protecting the kidneys against IRI, we wondered whether these two stimuli produced similar hemodynamic effects and whether the latter could conceivably account for the protection. Telemetric probes were implanted to record pulsatile arterial pressure (AP) from a carotid artery and the heart rate (HR) was ultimately derived from these recordings. As expected, restraint stress elevated AP (from 97.4 ± 3.1 to 112.2 ± 1 mmHg) and HR (from 423.4 ± 17.6 to 595.6 ± 18.2 bpm; n = 4; Fig. 8 a-c) . These changes persisted for at least another 10 min after the mice were returned to their home cage. By contrast, C1 stimulation at 5 Hz for 10 min lowered AP (from 110.1 ± 2 to 92 ± 2.5 mmHg) and HR (from 593.5 ± 22.6 to 461.3 ± 24 bpm; n = 4; Fig. 8d-f) , and these parameters returned to control less than a minute after the end of the stimulus (Fig. 8d-f ). 
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In short, C1 stimulation produced a cardiovascular response usually associated with freezing behavior (reduced locomotion, decreased HR) whereas restraint stress produced a pattern more reminiscent of fight or flight behavior (increased HR and arterial pressure) 36 . Both responses are associated with a reduction in renal and splanchnic blood flow 36 , suggesting that C1 stimulation and restraint stress could perhaps have protected the kidneys against IRI via ischemic preconditioning 37 . In order to test the plausibility of such interpretation, we determined whether 10 min of C1 stimulation in a conscious mouse produced a measurable increase in the renal level of hypoxiainducible factor 1α (Hif1a) transcripts. The renal Hif1a/Gapdh mRNA ratio was unchanged by C1 stimulation, but subjecting the kidneys of anesthetized mice to a short period of ischemia (10 min), which did not produce any detectable renal damage, increased this ratio significantly (no IRI versus IRI: P = 0.043; C1 vs. IRI: P = 0.025; Supplementary Fig. 6 ). In short, we found no evidence that C1 stimulation for 10 min produced renal ischemia.
DISCUSSION
This study demonstrated that acute restraint stress protected the kidneys from IRI and that C1 neurons were necessary and sufficient for this effect to occur. Restraint stress and C1 stimulation produced an equivalent degree of protection against renal IRI by three different measures: plasma creatinine, Kim1 transcripts and histological analysis of renal tubular damage. Like the protection against renal IRI elicited by ultrasound or vagal efferent stimulation 8, 27 , the beneficial effect of restraint stress or C1 stimulation was mediated by the splenic CAP. The protection elicited by C1 stimulation, though mediated by the autonomic nervous system, did not require the subdiaphragmatic vagus nerve. We conclude that C1 neurons could be a nodal point of the neuroimmune reflex mediated via the CAP and suggest that this anti-inflammatory pathway can be activated predominantly via a sympathetic rather than vagal preganglionic efferent pathway.
Mechanism of injury protection by stress and the C1 neurons C1 stimulation elevated plasma corticosterone, albeit to a lesser extent than restraint. Yet this hormone did not contribute detectably to the a r t I C l e S protection from renal IRI, because the protection was unaffected by the corticosteroid receptor antagonist mifepristone. While both restraint stress and C1 stimulation activate sympathetic nerve activity and probably reduce renal and splanchnic blood flow 36 , the degree of flow reduction is unlikely to be sufficient to trigger ischemic or remote ischemic preconditioning. Supporting this view, renal Hif1a mRNA level increased after mild renal ischemia (10 min) and has also been found to increase after remote ischemic preconditioning 37 but we detected no such increase after C1 stimulation. The autonomic nervous system and the spleen were clearly implicated in the injury protection elicited by restraint stress or C1 stimulation because splenectomy, ganglionic blockade or administration of a selective β 2 -adrenergic receptor antagonist eliminated the protection. In addition, renal IRI protection could be conferred to naive mice by transferring splenocytes harvested from stressed mice or by injecting them with noradrenaline-treated CD4 splenic lymphocytes. Finally, stress had no beneficial effect in a7nAChR −/− mice. The latter evidence does not implicate specifically the α7nAChRs that are located on splenic macrophages, since this receptor type is also expressed within the CNS and by sympathetic efferent neurons, but it is consistent with the notion that the renal protection is mediated by the CAP as originally defined 2,3,11 . The renal protection elicited by stress or C1 stimulation seems to operate via the same peripheral mechanism as that produced by peripheral vagus nerve stimulation or noninvasive ultrasound 8, 27 . In each case, protection was absent in a7nAChR −/− mice, eliminated by splenectomy and was transferrable to naive mice by administration of splenic T-lymphocytes harvested from animals previously subjected to the protective stimulus. In the case of ultrasound, no protection was observed in mice deficient in functional T-and B-lymphocytes (Rag1 −/− ) and protection could be reinstated by administering wild-type CD4 + T cells intravenously unless the spleen was excised 27 . We have not yet tested whether stress or C1 stimulation fails to protect the kidneys from IRI in Rag1 −/− mice, but this outcome is likely.
The present study does not further clarify how the kidneys are ultimately protected from injury after the spleen is activated. In the case of vagus nerve stimulation, the protection correlates with a reduction in renal granulocyte infiltration, a decrease in the concentration of inflammatory cytokines in the plasma and the renal parenchyma, and a possible M1-to-M2 phenotypic shift of circulating macrophages 8 .
Vagal versus sympathetic routes of activation of the CAP
The CAP requires the activation of the splenic nerve 2,11 , which is presumed to consist almost entirely of noradrenergic axons with cell bodies located in the suprarenal and celiac ganglia 9, 38 . Under anesthesia, most active splenic nerve fibers are reportedly under arterial baroreceptor control; these efferent fibers presumably innervate the spleen vasculature and derive their ongoing activity from the brainstem via sympathetic preganglionic neurons 39 . The white pulp of the spleen, especially the central region that harbors the T-lymphocytes, also receives a dense noradrenergic innervation, which likely mediates the CAP. There is mounting, albeit incomplete, evidence that the noradrenergic neurons innervating the spleen receive input from both vagal and sympathetic preganglionic neurons 2, 14 . Supporting the vagal efferent hypothesis, renal IRI protection and other CAP-related effects are elicited by stimulating the peripheral end of a cut vagus nerve 8, 40 . Such results implicate vagal efferent neurons or, less likely, an axon reflex. Anatomical connections between the dorsal motor nucleus of the vagus and the spleen have been detected, although not by all investigators 38, 41, 42 and anatomical contacts between vagal preganglionic neurons and prevertebral ganglionic (presumably noradrenergic) neurons have also been described 43 , although evidence that these ganglionic neurons innervate the spleen is yet to be produced 38 .
In the present study, the renal protection produced by C1 stimulation was greatly attenuated by ganglionic blockade but was unaffected by subdiaphragmatic vagal denervation. This evidence does not rule out the possibility that stress or C1 stimulation could also activate the catecholaminergic neurons that regulate splenic T cells via a vagal preganglionic route, especially since C1 stimulation activates vagal efferents. However, the present evidence indicates that activation of sympathetic efferents was sufficient to activate the CAP and elicit the protection. A similar sympathetic mechanism contributes to the immunosuppressive effects of anesthesia or spinal transection 13, 15 , two conditions under which sympathetic tone can be extremely elevated.
C1 cells: beyond cardiovascular homeostasis C1 neurons are glutamatergic and catecholaminergic, and they differentially express several neuropeptides (for example, neuropeptide Y, substance P, enkephalin) 23 . Subsets of these neurons are believed to operate as a switchboard for eliciting behaviorally appropriate patterns of autonomic responses 23, 44, 45 . Only a third of the C1s innervate sympathetic preganglionic neurons 46 . These particular C1s contribute to blood pressure and glucose homeostasis via sympathetic reflexes that are predominantly organized at lower levels of the neuraxis 22, 23, 47 . In addition to their homeostatic function, C1s also have an allostatic role (arousal from sleep, freezing behavior, cardiorespiratory adjustments), which is revealed when they are selectively activated (see ref. 45 and present results). One interpretation of the present study is that a subset of C1s, currently unidentified, regulates the immune system during psychological and possibly other forms of stress 24 . The predominantly sympathetic activation route of the anti-inflammatory splenic mechanism elicited by C1 stimulation suggests that this subset of C1s could be bulbospinal. However, this argument is not compelling. Bulbospinal and hypothalamus-projecting C1s also target a common set of CNS structures that are implicated in autonomic regulations (dorsal vagal complex, parabrachial nuclei, periaqueductal gray matter, locus coeruleus and other noradrenergic neurons) 29, 30 ; activation of any one of these structures could ultimately increase sympathetic efferent activity and activate the CAP via descending pathways other than the bulbospinal C1s 30 . C1s belong to the lower brainstem reticular core and respond to a wide variety of stimuli; for example, they are excited by restraint stress and by somatic as well as by visceral, notably vagal, afferents 23, 48 . This vagal sensory input could explain why activating the central end of a divided vagal nerve also protects the kidneys from IRI 8 . This broad set of inputs, combined with the ability of C1 to activate parasympathetic and sympathetic efferents 29 , may explain why the CAP can be activated by triggers as diverse as stimulation of vagal afferents or efferents, stimulation of the auricular nerve 49 , stress and electroacupuncture 50 . In other words, CAP activation may be one of a constellation of stereotyped effects (arousal, cardiorespiratory stimulation) elicited or facilitated by C1 in response to internal or external 'danger' signals. Intense or artificially synchronized afferent-fiber activity, such as that produced by repetitive electrical stimulation of the vagal nerve or subsets of somatic afferents (acupuncture), may be such a trigger.
In conclusion, C1 mediated the protective effect of stress against renal IRI by activating the CAP. In this particular case the CAP seems to have been activated via a sympathetic rather than vagal route. This study also provides proof of principle that localized brain stimulation can produce beneficial anti-inflammatory effects.a r t I C l e S METhODS Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ONLINE METhODS
Animals. Animal use was in accordance with the NIH Guide for the Care and Use of Laboratory Animals and was approved by the University of Virginia Animal
Care and Use Committee. Dbh Cre/0 mice were obtained from the Mutant Mouse Regional Resource Center at the University of California, Davis, CA (Tg(DßH-cre)KH212Gsat/Mmcd; stock no. 032081-UCD). Dbh Cre/0 mice were maintained as hemizygous (Cre/0) on a C57BL/6J background. A total of 182 Dbh Cre/0 male mice (DBH-cre), aged between 10 and 14 weeks, were used for these experiments. Chrna7 −/− (referred to as α7KO) mice (B6.129S7-Chrna7tm1Bay/J) were obtained from Jackson Laboratories, and WT (Chrna7 +/+ ) progeny were used as controls in this experiment (n = 12 α7WT mice and n = 10 α7KO mice). For the adoptive transfer (n = 56) and Fluorogold (FG, n = 6) experiments, we used WT NCI C57BL/6 mice that were purchased from Charles River Laboratories.
Viral vectors.
AAV-DIO-EF1α-ChR2(H134R)-mCherry serotype 2 (AAV2-ChR2-mCherry), AAV-DIO-EF1α-mCherry serotype 2 (AAV2-mCherry), AAV2-DIO-taCasp3-TEVp and AAV-DIO-hSyn-hm4D(Gi)-mCherry were purchased from the University of North Carolina vector core (the first two constructs courtesy of K. Deisseroth (Stanford University), third construct courtesy of N. Shah (University of San Francisco), fourth construct courtesy of B. Roth (University of North Carolina)). AAV2-ChR2-mCherry expresses an enhanced version of the photosensitive cationic channel ChR2 (ChR2(H134R)) fused to the fluorescent reporter mCherry. In these vectors, the ChR2-mCherry (AAV2-ChR2-0mCherry), mCherry (AAV2-mCherry), taCasp3-TEVp and hm4D(Gi)-mCherry sequences are flanked by the same double-lox sites (LoxP and lox2722).
Injections of viral vector into the rostral ventrolateral medulla (RVlm) and optical fiber placement. AAV2-ChR2-mCherry or AAV2-mCherry was injected unilaterally into the left RVLM; this was followed by placement of an optical fiber. AAV2-DIO-taCasp3-TEVp and AAV2-DIO-hSyn-hm4D(Gi)-mCherry were injected bilaterally into the RVLM; optical fibers were not installed in these mice. The injections were made under aseptic conditions in mice anesthetized with a mixture of ketamine (100 mg/kg) and dexmedetomidine (0.2 mg/kg; i.p.). Depth of anesthesia was deemed sufficient if the corneal and hindpaw withdrawal reflexes were absent. Additional anesthetic was administered as necessary (10% of the original dose, i.p.). Body temperature was maintained at 37.0 ± 0.5 °C with a servo-controlled temperature pad (TC-1000; CWE). The mandibular branch of the facial nerve was revealed through a small skin incision (left side or both sides as required) for later electrical stimulation. The mice were then placed prone on a Kopf 1730 stereotaxic apparatus adapted for mouse stereotaxic injections (ear bar adaptor, model EB-5N; Narishige Scientific Instrument Lab; bite bar, Model 926 mouse adaptor set at −2 mm; David Kopf Instruments). The viral vector was loaded into a glass pipette with a 1.2-mm internal diameter, broken to a 25-µm tip (external diameter) and introduced into the brain through a 1.5-mm-diameter hole that was drilled into the occipital plate caudal to the parieto-occipital suture on the left side (or on both sides). The facial nerve was stimulated (0.1 ms, 1-300 µA, 1 Hz) to evoke antidromic field potentials within the facial motor nucleus 29 . These field potentials, recorded via the vector-filled pipette, were used to map the caudal end of the facial motor nucleus (FN) and thus identify the location of C1s that reside immediately caudal to this nucleus. For unilateral administration of vector, three 140-nL injections were made 300 µm above the base of the medulla oblongata (determined as the lower limit of the facial field potential) and at the medial edge of the respiratory column (identified by respiratory synchronous multiunit activity). The three injections were separated by 200 µm and were aligned rostrocaudally. Next, an optical fiber (125-µm core after desheathing; 0.39 numerical aperture; Thorlabs) was inserted 300 µm above the injection site (fiber tip ~4.7 mm ventral to the dorsal surface of the brain) and then secured to the skull with cyanoacrylate adhesive. Prior to implantation the optical fibers were glued into a zirconia ferrule (outside diameter, 1.25 mm; bore, 130 µm; Precision Fiber Products). The light output of each optical fiber was measured with a light meter (Thorlabs), and the laser setting required to deliver 10 mW was recorded. This setting was later used during the in vivo experiments. The stereotaxic procedure used for bilateral injection of AAV2-DIO-taCasp3-TEVp or AAV2-DIO-hSyn-hm4D(Gi)-mCherry into the RVLM was the same except that no optical fiber was inserted.
Mice received postoperative boluses of atipamezole (α 2 -adrenergic antagonist, 2 mg/kg, s.c.), ampicillin (125 mg/kg, i.p.) and ketoprofen (4 mg/kg, s.c.).
Ampicillin and ketoprofen were readministered 24 h postoperatively. Mice were housed in the University of Virginia vivarium for at least 4 weeks after virus injection. Mice were maintained in groups of 3-5 per cage on a 12:12-h light: dark cycle. During this time, mice gained weight normally and appeared unperturbed by the implanted optical fiber. These mice were randomly divided into the various treatment groups.
whole-body plethysmography. Optogenetic stimulation of C1 produces a frequency-dependent increase in breathing frequency and amplitude 48 . Breathing patterns evoked by brief periods of C1 photostimulation (10 s) were therefore routinely measured in conscious mice to ensure that C1s were effectively transduced to express ChR2 and that the optical fiber was correctly implanted. Breathing was measured in conscious mice using unrestrained whole-body plethysmography (EMKA Technologies), as described previously 26 . The chamber was continuously flushed with dry, room-temperature air (23 -26 °C) delivered at 0.5 standardized liters per min. Fluctuations in chamber pressure were amplified (×500) and acquired at 1 kHz with Spike 2 software (v7.06; CED). Respiratory frequency (fR; breaths/min) was measured during periods of behavioral quiescence. The measurements were made between 10:00 a.m. and 4:00 p.m. Mice were placed in the plethysmography chamber and habituated to chamber conditions for 2-3 h. At this point, mice were briefly anesthetized with isoflurane while the connection between the implanted fiber optic and the laser was established. Recordings were initiated at least 30 min after the mice had regained consciousness and only during periods of behavioral quiescence. To evaluate the effects of photostimulation on fR, 10-s trains of light pulses (duration, 10 ms) were delivered at various frequencies (5, 10, 15 and 20 Hz). The minority of DBH-cre mice that had received injections of AAV2-ChR2-mCherry and did not have a detectable breathing stimulation at 5 Hz were not included in the experimental group (10 of 182). These mice were used as a control group (no laser group in renal IRI or corticosterone experiment).
Splenectomy. DBH-cre mice (n = 12) were anesthetized with an i.p. injection of ketamine (120 mg/kg) and xylazine (12 mg/kg). Depth of anesthesia was assessed by absence of the corneal and hindpaw withdrawal reflexes. Additional anesthetic was administered as necessary (10% of the original dose, i.p.). Body temperature was maintained at 37.0 ± 0.5 °C with a servo-controlled temperature pad (TC-1000; CWE). A small flank incision was performed through which the splenic vasculature was ligated and the spleen removed. Mice received boluses ketoprofen (4 mg/kg, s.c.) immediately after surgery and again 24 h later. These mice were allowed to recover for 7 d before renal IR.
Subdiaphragmatic vagotomy. Subdiaphragmatic vagotomy (sVNX) was performed in 6 DBH-cre mice that had received injections of AAV2-ChR2-mCherry into the RVLM one week before testing the effect of C1 stimulation on renal IRI. The mice were anesthetized with an i.p. injection of ketamine (120 mg/kg) and xylazine (12 mg/kg). Depth of anesthesia was assessed by absence of the corneal and hindpaw withdrawal reflexes. Additional anesthetic was administered as necessary (10% of the original dose, i.p.). Body temperature was maintained at 37.0 ± 0.5 °C with a servo-controlled temperature pad (TC-1000; CWE). After middle upper laparotomy, the stomach was gently manipulated to expose the esophagus. Then, both anterior and posterior trunks of the vagal nerves were identified between the diaphragm and the gastric cardia and then transected. In the sham-operated animals (10 DBH-cre mice), the abdominal vagal nerves were similarly exposed but not cut. Mice received boluses of ampicillin (125 mg/kg, i.p.) and ketoprofen (4 mg/kg, sc) immediately after surgery and again 24 h later. Six additional mice (C57BL/6) were used to test the efficacy of the denervation procedure. Three mice were subjected to sVNX and the rest underwent sham surgery, as described above. Seven d after surgery the mice received an i.p. injection of 200 µl of 1% Fluorogold. After 4 d, the mice were deeply anesthetized and perfused. Brains were removed and postfixed in 4% paraformaldehyde for up to 3 d, and then all brains were sectioned as described below.
Arterial pressure and heart rate measurement in conscious mice subjected to c1 stimulation or restraint stress. The cardiorespiratory effects (AP, HR, breathing parameters) produced by unilateral optogenetic stimulation of C1s were examined in 10 DBH-cre mice prepared as described above. These mice were implanted with a radio-telemetry probe (PA-C10; Data Sciences International) 3 weeks after injection of AAV2-ChR2-mCherry into the RVLM to measure AP (right common carotid artery). A separate cohort of 4 DBH-cre mice was used to measure the effect of 10 min of restraint stress (method described below) on AP and HR; breathing was not measured in these mice. For arterial pressure probe implantation, mice were anesthetized with an i.p. injection of ketamine (120 mg/kg) and xylazine (12 mg/kg), and their body temperature kept at 37.0 ± 0.5 °C. Depth of anesthesia was assessed by absence of the corneal and hindpaw withdrawal reflexes. Additional anesthetic was administered as necessary (10% of the original dose, i.p.). AP and HR were measured a minimum of 1 week after arterial probe implantation using a PhysioTel Receiver (RLA 1020; Data Science International). Mean AP and HR were calculated from pulsatile AP recordings based on values calibrated before implantation of the telemetry probe. For optogenetic experiments only, the mice were placed in the plethysmography chamber in order to record respiratory parameters along with pulsatile AP. Breathing parameters (fR, Vt, MV) were extracted as described earlier.
In one set of 6 DBH-cre mice, we examined the effects of brief (10-s) periods of C1 photostimulation delivered at various frequencies (5, 10, 15 and 20 Hz) during behavioral quiescence. This experiment showed that 5-Hz stimulation produced a reliable and submaximal breathing stimulation. On that basis, 5 Hz was selected to examine the effects of longer periods of stimulation on renal IRI (10 min). The effect of 10 min of C1 stimulation at 5 Hz on AP, HR and breathing was examined in 4 DBH-cre mice. The effect of 10 min of restraint stress (restraint method described below) on AP and HR was evaluated in a separate cohort of 4 DBH-cre mice.
nerve recordings in urethane-anesthetized mice. These experiments on anesthetized mice were designed to examine the consequences of C1 optogenetic stimulation on the sympathetic and parasympathetic efferent activities. Vagus nerve activity (VNA) evoked by optogenetic stimulation of C1 cells at various frequencies was recorded in 12 urethane-anesthetized DBH-cre mice (1.6 g/kg urethane i.p. given as a 20% w/v solution). These mice had received injections of AAV2-ChR2-mCherry 4-5 weeks prior and also had an implanted radiotelemetry probe for blood pressure measurement. Depth of anesthesia was assessed by absence of the corneal and hindpaw withdrawal reflexes. Additional anesthetic was administered as necessary (10% of the original dose, i.p.). Body temperature was maintained at 37.0 ± 0.5 °C with a servo-controlled temperature pad (TC-1000; CWE). Following induction of anesthesia, the preimplanted optical fiber was connected to the laser, and mice were placed supine in a stereotaxic frame. A tracheostomy was performed, and mice were mechanically ventilated with pure oxygen (170-220 rpm at 7-8 µL/g; MiniVent type 845; Hugo-Sachs Electronik). In 6 DBH-cre mice, we recorded from the left vagus nerve and the left renal sympathetic nerve simultaneously. In the other 6 mice, we recorded from the right vagus nerve only (the sympathetic nerve was not recorded). To record VNA, a ~15-mm segment of the cervical vagus nerve (left or right) was dissected free of the carotid artery and the cervical sympathetic chain, and the peripheral end of the isolated vagus nerve segment was crushed. The contralateral vagus nerve was always left intact. A renal sympathetic nerve bundle was isolated through a left flank incision. The vagus nerve was placed on a bipolar stainless wire electrode (AS633; Cooner Wire) that was positioned rostral to the crush in order to measure multifiber efferent VNA. The renal nerve bundle was placed uncut on identical bipolar stainless steel electrodes. Electrodes and nerves were then embedded in silicone (Kwik-Sil, WPI). Next, the adequacy of anesthesia was rechecked, and the muscle relaxant agent vecuronium was administered (0.1 mg/kg, i.p.). After this point, the adequacy of the anesthesia was determined by the absence of change in AP and HR in response to a firm hindpaw pinch. Physiological signals were filtered and amplified (AP, 10-1,000 Hz, ×1,000; vagus nerve, 30-3,000 Hz, ×10,000; renal nerve: 30-1,000 Hz, ×10,000; BMA-400 amplifier, CWE). The analog signals were digitized (Micro3 1401; CED) and processed using Spike 2 software (v7.06; CED). VNA was high-pass filtered (100 Hz; transition, 50 Hz) when the signal contained a substantial electrocardiogram contamination. The final signal processing consisted of half-wave rectification and averaging. AP and HR were recorded as described above. At the end of the experiment, the vagus nerve was cut on the cephalic side of the recording electrode to measure the electrical noise and, if applicable, the ganglionic blocker hexamethonium bromide was administered (30 mg/kg, i.m.) to eliminate renal sympathetic nerve activity (RSNA) and record the portion of the signal representing the electrical noise. The background noise was systematically subtracted and the balance was taken as efferent VNA or RSNA. These multifiber recordings were subject to considerable interanimal variation in amplitude because of differences in electrode configuration, current leak via extracellular fluid and other factors. The effect of trains of C1 stimulation (10 s, 5-20 Hz) on VNA and RSNA was therefore normalized by measuring the ratio between the mean nerve activity present while the 10-s stimulus was being applied and the resting activity present during the 10 s preceding the stimulus (both values background subtracted). The nerve activity evoked by low-frequency stimulation of C1 (1 Hz) was determined by constructing peristimulus waveform averages of the half-wave rectified signal (200 sweeps). The amplitude of the peak evoked response was expressed as a percent of the prestimulus value of the nerve activity after background noise subtraction. Sham C1 photostimulation (dummy) was done by setting the laser output to 0 mW. optogenetic activation of c1 and renal IRI. The effect of C1 stimulation on renal IRI was examined in DBH-cre mice that had previously received injections of AAV2-ChR2-mCherry or AAV2-mCherry into the left RVLM. These experiments required 90 mice. The breakdown of the various experimental groups and treatments (laser light, drugs, vector) is shown in Supplementary Table 1 for added clarity. All the mice included in Supplementary Table 1 were subjected to bilateral renal IRI the day after the treatment indicated in the table. Each experiment also included 12 mice that were not subjected to renal IRI (not shown on the table) in order to ascertain that their creatinine was appropriately low.
Every mouse also carried an implanted optical fiber. Photostimulation of C1s (DBH-cre mice with injections of AAV2-ChR2-mCherry) or sham stimulation (same trains of laser light delivered to DBH-cre mice injected with AAV2-mCherry) was done while the mice were confined to a plethysmography chamber. The mice were placed in one of these chambers for 2 h twice a week for 2 weeks in order to habituate them to this environment and thus minimize the associated stress. Laser light produced no effect of any kind (cardiorespiratory, behavior, corticosterone) in DBH-cre mice injected with control vector (ChR2-mCherry), and therefore we presume that the light activated C1s only when these neurons expressed ChR2.
The mice were briefly anesthetized with isoflurane while the connection between the implanted fiber optics and the laser was established. Drugs were given i.p. 30 min later (30 mg/kg hexamethonium bromide, a ganglionic blocker, n = 6; 30 mg/kg labetalol, a nonselective β 1/2 -and α1-adrenergic receptor antagonist, n = 6; 15 mg/kg butoxamine, a selective β 2 -adrenergic receptor antagonist, n = 6; or 30 mg/kg mifepristone, a corticosterone receptor antagonist, n = 6). A group of control mice received the volume of vehicle used to dissolve the drugs (0.9% NaCl solution i.p. for all drugs except mifepristone; 100% dimethylsulfoxide (DMSO) was used as a control for mifepristone; n = 6). Thirty min after drug or vehicle administration, light pulses (10 ms duration, 5 Hz) were delivered for 10 min. Control mice were briefly anesthetized with isoflurane but photostimulation was not applied.
Twenty-four h after applying the light pulses to the RVLM, mice were anesthetized with i.p. injections of ketamine (120 mg/kg) and xylazine (12 mg/kg), and bilateral flank incisions were made to access the kidneys. Renal IRI, as previously described 8 , was produced by clamping the renal pedicles for exactly 26 min in 88 DBH-cre mice. The clamps were then removed and the wound sutured after restoration of blood flow was visually observed. Kidneys were allowed to reperfuse for a period of 24 h. This surgical procedure was conducted blind, i.e., the person performing the renal clamp had no knowledge of which combination of drug and optogenetic protocol the mice had been subjected to one day earlier. Mice received ketoprofen (4 mg/kg) and ampicillin (125 mg/kg) after surgery. Twentyfour h after renal IR, the mice were euthanized with an overdose of ketamine and xylazine, and blood (400-600 µL) was collected from the orbital sinus. The kidneys were harvested for histology and extraction of RNA for Kim1 transcript measurement. Finally, the descending aorta was clamped, the animal was perfused through the heart with 4% paraformaldehyde and the brain was collected for histology (see sections on renal and brain histology for details).
effect of 10-min c1 stimulation or 10-min renal ischemia on renal Hif1a mRnA. These experiments were done in order to determine whether 10 min of C1 stimulation in a conscious mouse produced a measurable increase in the renal level of Hif1a transcripts indicative of a possibly severe hypoperfusion. The experiments used three groups of mice. Group 1 consisted of unanesthetized DBH-cre mice with AAV2-ChR2-mCherry injections and a preimplanted optical fiber; C1s were not stimulated in this group (no light was applied). Group 2 comprised identically prepared DBH-cre unanesthetized mice, in which C1s were optogenetically stimulated for 10 min using our standard parameters (10-ms pulses, 5 Hz). Group 3 mice were anesthetized with an i.p. injection of ketamine (120 mg/kg) and xylazine (12 mg/kg) and subjected to 10 min of complete bilateral renal ischemia. The kidneys were harvested 10 min after cessation of C1 stimulation (group 2), sham stimulation (group 1, no light applied) or ischemia (group 3). Groups 1 and 2 were anesthetized with an i.p. injection of ketamine (120 mg/kg) and xylazine (12 mg/kg) before harvesting the kidneys. effect of restraint stress on renal IRI. The effect of restraint stress on renal IRI was also examined in DBH-cre mice. A subset of DBH-cre mice had previously received bilateral microinjections of AAV2-DIO-hSyn-hm4D(Gi)-mCherry (DREADD, n = 12) or AAV2-DIO-taCasp3-TEVp (caspase, n = 12) into the RVLM. A total of 48 mice was required for these experiments. The breakdown of the various experimental groups (mouse strain, vector and drug) is shown in Supplementary Table 2 . All the mice shown in Supplementary Table 2 were subjected to 26-min renal ischemia followed by 24 h of reperfusion.
For the DREADD experiments, the receptor agonist CNO (Sigma-Aldrich, 3 mg/kg, n = 6) or its vehicle (saline; n = 6) was injected 30 min before restraint stress. For restraint stress, each mouse was placed in an adequately ventilated 50-mL conical plastic tube (Corning Inc.) for 10 min (n = 36 DBH-cre). They could rotate from a prone to supine position and back again but not turn head to tail. Nonrestrained mice were left undisturbed in their home cages (n = 12 DBH-cre). DBH-cre mice with bilateral injections of AAV2-DIO-taCasp3-TEVp were either subjected to restraint stress or left in their home cage.
Twenty-four h after restraint stress, mice were anesthetized with an i.p. injection of ketamine (120 mg/kg) and xylazine (12 mg/kg), and bilateral renal clamping was performed for 26 min as described in the previous section (n = 48 DBH-cre mice). Mice received ketoprofen (4 mg/kg) and ampicillin (125 mg/kg) after surgery. Twenty-four h after renal IR, the animals were euthanized with an over dose of ketamine (120 mg/kg) and xylazine (12 mg/kg) and the blood was collected from the orbital sinus for creatinine measurement. Next, we harvested the kidneys for histology and Kim1 mRNA measurement, and the mice were perfusion-fixed with paraformaldehyde. Finally the brains were removed for histology. effect of c1 stimulation or restraint stress on plasma corticosterone. The effect of C1 stimulation on plasma corticosterone and related controls was examined in DBH-cre mice that had previously received injections of AAV2-ChR2-mCherry or AAV2-mCherry into the left RVLM. Every mouse also carried an implanted optical fiber. Four weeks after this procedure, the DBH-cre mice that had received injections of AAV2-ChR2-mCherry were placed in a plethysmography chamber and short trains of light pulses (10 s, 5-20 Hz) were applied to ascertain that breathing was stimulated, thereby indicating that C1s were properly activated. During the next 2 weeks, each mouse was habituated to the plethysmography cage for 2 h twice a week. The actual experiment was conducted on week 7. Mice were briefly anesthetized with isoflurane while the connection between the implanted fiber optic and the laser delivery system was established, and 10-ms light pulses were delivered for 10 min at 5 Hz. This procedure was carried out in 9 DBH-cre mice. In order to control for the effect of the light itself and for any untoward effect of the vector, we performed two control experiments. For the first control experiment we used 9 DBH-cre mice with AAV2-ChR2-mCherry. Following connection of the optical fiber with the laser and placement of the mice in the customary environment (plethysmography chamber), no light was applied. The second control experiment was done in mice that had been injected with control virus (AAV2-mCherry). These mice (6 DBH-cre) received the same light pulses (5 Hz, 10 ms, 10 min) as the experimental group while in the same environment. All these experiments were conducted between 1 and 5 p.m.
For restraint stress, each mouse (DBH-cre) was placed in an adequately ventilated 50-mL conical plastic tube (Corning Inc.) for 10 min. The mice could rotate from a prone to supine position and back again but could not turn head to tail. Six DBH-cre mice were subjected to this treatment. Control mice (6 DBHcre) were left undisturbed in their home cages. These experiments were also performed between 1 and 5 p.m.
